Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Editorial: Multi-organ linkage...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Editorial: Multi-organ linkage pathophysiology and therapy for NAFLD and NASH

Editorial: Multi-organ linkage pathophysiology and therapy for NAFLD and NASH

Bibliographic Details
Main Authors: Takefumi Kimura, Tomoo Yamazaki, Gabriel Rufino Estrela
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-06-01
Series:Frontiers in Endocrinology
Subjects:
non alcoholic fatty liver disease (NAFLD)
non-alcoholic steatohepatitis (NASH)
metabolic dysfunction-associated steatotic liver disease (MASLD)
metabolic dysfunction-associated steatohepatitis (MASH)
multi-organ linkage
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1418066/full
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2024.1418066/full

Similar Items

  • The Multicomponent Medicinal Product Hepar Compositum Reduces Hepatic Inflammation and Fibrosis in a Streptozotocin- and High-Fat Diet-Induced Model of Metabolic Dysfunction-Associated Steatotic Liver Disease/Metabolic Dysfunction-Associated Steatohepatitis
    by: Yvonne Burmeister, et al.
    Published: (2023-12-01)
  • Sex-based differences in natural killer T cell-mediated protection against diet-induced steatohepatitis in Balb/c mice
    by: Carlos Cuño-Gómiz, et al.
    Published: (2023-11-01)
  • Myosteatosis: Diagnosis, pathophysiology and consequences in metabolic dysfunction-associated steatotic liver diseaseKey points
    by: Guillaume Henin, et al.
    Published: (2024-02-01)
  • NAFLD: Mechanisms, Treatments, and Biomarkers
    by: Fatiha Nassir
    Published: (2022-06-01)
  • Steatotic Liver Disease: Metabolic Dysfunction, Alcohol, or Both?
    by: Katharina Staufer, et al.
    Published: (2023-07-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs